Você está deixando o Portal Médico GSK

Você está prestes a deixar o site da GSK. Ao clicar neste link, você será direcionado a um site que não pertence ou é controlado pela GSK. Portanto, a GSK não é responsável por demais conteúdos presentes neste site.

Continuar

Voltar

PAGINAPORTALMEDICO-CRM

Cobertura ATS 2018

Você mais próximo do American Thoracic Society Meeting! Fique por dentro dos debates que aconteceram durante o congresso com nosso time de especialistas GSK e convidados. 

 

Cobertura Asma: confira os destaques em asma de todo o ATS 2018

  • 1. PONGRACIC, JA. ET AL. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. J Allergy Clin Immunol, 138: 1030-1041, 2016;

    2. GLOBAL INITIATIVE FOR ASTHMA. Global strategy for asthma management and prevention. Disponível em: < https://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/> Acesso em: 27 jun 2018;

    3. PAPI, A. et al. Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med, 1: 23–31, 2013.

    4. BATEMAN, ED. et al. As-needed budesonide–formoterol versus maintenance budesonide in mild asthma. N Engl J Med, 378: 1877-87, 2018.

    5. WOODCOCK, A. et al. Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial. Lancet, 390(10109):2247-2255, 2017;

    6. O´CONNOR, GT. et al. Early-life home environment and risk of asthma among inner-city children. J Allergy Clin Immunol, 141(4):1468-1475, 2018;

    7. ALBERS, FC. et al. Durability of Clinical Response Following Long-Term Treatment with Mepolizumab in Patients with Severe Eosinophilic Asthma: The COLUMBA Study. Am J Respir Crit Care Med, 197:A1372, 2018;

    8. NAGAKUMAR, P. et al. Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol, 137(2):624-626.e6, 2016;

    9. ZORATTI, EM. et al. Asthma phenotypes in inner-city children. J Allergy Clin Immunol, 138(4):1016-1029, 2016;

    10. ALBERS, FC. et al. Durability of clinical response following long-term treatment with mepolizumab in patients with severe eosinophilic asthma: the COLUMBA study. Am J Respir Crit Care Med, 197: A1372, 2018;

    11. WENZEL, S. et al. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med, 18(5): 716-25, 2012.